GL1X · GenesisL1 explorer

MolNFT v1 · #257022 · protein

AlphaFold monomer V2.0 prediction for probable nicotinate-nucleotide adenylyltransferase (Q16AV3)

Q16AV3: “AlphaFold monomer V2.0 prediction for probable nicotinate-nucleotide adenylyltransferase (Q16AV3)”. 1 pocket (best druggability 0.61). MolNFT v1 #257022 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

Accession
Q16AV3
Type
protein
Length
199 residues
Chains
1
Collection
MolNFT v1 / AlphaFold
Contract
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
Owner
0xa7a8Bd7Dd8aC3831b90C08d397E1a831845f1D28
Molecule
Probable nicotinate-nucleotide adenylyltransferase
UniProt
Q16AV3
Pockets
1 · best druggability 0.61

Structure

1 distinct chain · 43% helix, 18% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AProbable nicotinate-nucleotide adenylyltransferaseprotein19943% helix, 18% strandQ16AV3

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14130.610.7642empty

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.